We further determined the role of p21 downregulation in promoting EIF1AX‐dependent breast cancer cell proliferation by knocking down both p21 and EIF1AX to determine whether p21 knock‐down could rescue the EIF1AX knock‐down‐induced accumulation of cells in the G0/G1 phase. Here, CDKN1A is linked to breast carcinoma.